RAMP - RAMP ライブランプ （）

LiveRamp has shown resilience amid macroeconomic slowdown and ad spending pressure, maintaining double-digit growth in FY 2023. Read why RAMP stock is a Buy.

Benzinga Pro data, LiveRamp Holdings (NYSE: RAMP ) reported Q4 sales of $148.63 million. Earnings fell to a loss of $31.36 million, resulting in a 5.66% decrease from last quarter. LiveRamp Holdings collected $158.62 million in revenue during Q3, but reported earnings showed a $29.68 million loss. What Is ROCE? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company … Full story available on Benzinga.com

The following slide deck was published by LiveRamp Holdings, Inc.

LiveRamp Holdings, Inc. (NYSE:NYSE:RAMP) Q4 2023 Earnings Conference Call May 24, 2023 4:30 PM ETCompany ParticipantsDrew Borst - Vice President, Investor RelationsScott Howe - Chief…

LiveRamp press release (RAMP): Q4 Non-GAAP EPS of $0.32 beats by $0.14.Revenue of $149M (+4.9% Y/Y) misses by $0.63M.For the first quarter of fiscal 2024, LiveRamp expects…

LiveRamp Holdings Inc. (NYSE:RAMP) concluded the trading at $21.07 on Friday, November 25, with a fall of -0.75% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $21.23 and 5Y monthly beta was reading 1.12 with its price kept floating in the … LiveRamp Holdings Inc. (RAMP) Is Worth Investing In Read More »

Ongoing subscription growth and new-customer wins are driving results.

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session. Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) shares climbed 219% to $12.80 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $450 million in milestone payments for the pancreatic cancer treatment. Outset Medical, Inc. (NASDAQ: OM ) surged 36.1% to $15.61 after the company reported better-than-expected Q3 results. OptimizeRx Corporation (NASDAQ: OPRX ) climbed 28% to $18.58 following better-than-expected Q3 results. Health Catalyst, Inc. (NASDAQ: HCAT ) rose 23% to $7.95 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates. Vivint Smart Home, Inc. (NYSE: VVNT ) gained 21.4% to $8.50 after the company posted upbeat quarterly sales and raised FY22 revenue guidance. LiveRamp Holdings, Inc. (NYSE: RAMP ) rose 21% to $18.91 after the company reported better-than-expected Q2 results and issued strong guidance.

https://www.investing.com/news/pro/liveramp-holdings-inc-pt-lowered-to-25-at-evercore-isi-432SI-2937231

LiveRamp Holdings, Inc. (NYSE:NYSE:RAMP) Q2 2023 Results Conference Call November 08, 2022 04:30 PM ET Company Participants Drew Borst - Vice President of Investor Relations Scott Howe -…

LiveRamp Holdings Inc. (NYSE:RAMP) price closed higher on Tuesday, June 14, jumping 0.84% above its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << A look at the daily price movement shows that the last close reads $25.09, with intraday deals fluctuated between $24.48 and $25.545. … LiveRamp Holdings Inc. (NYSE: RAMP): Still A Hot Buy? Read More »

CONWAY, Ark.--(BUSINESS WIRE)--Acxiom®, the customer intelligence company whose data-driven solutions create business growth by enabling better customer experiences, today announced the launch of Match Multiplier, an application that will facilitate data sharing by allowing brands to increase the reach of their data with additional match keys natively in the Snowflake Data Cloud. The need for privacy-safe data sharing to achieve marketing performance metrics is greater than ever, and Match Mult

LiveRamp with AppExchange enables customers to accelerate their digital transformation journeys and extend the full power of Salesforce Marketing Cloud Customer Data Platform (CDP) LiveRamp announced it has joined the expanded Marketing Cloud Customer Data Platform ecosystem on Salesforce AppExchange, empowering brands to understand their customers, drive personalization at scale, and unlock new opportunities that accelerate business […] The post LiveRamp Joins Salesforce AppExchange, the World’s Most Trusted Enterprise Cloud Marketplace appeared first on MarTech Series .

SAN FRANCISCO--(BUSINESS WIRE)--LiveRamp with AppExchange enables customers to accelerate their digital transformation and extend the power of Salesforce Marketing Cloud CDP

Havas'' LiveRamp partnership takes expensive research and development costs out of the agency’s hands.